U.S. Stocks · 10-Year SEC Financials

Eli Lilly vs. Johnson & Johnson Financial Comparison

High-growth metabolic/oncology pharma vs. diversified pharma & medtech across growth, margins and valuation.

Market Scale & Valuation Snapshot

Market prices reflect recent closing quotes (LLY: 2026-11-04 · JNJ: 2026-11-04).

MetricELI LILLY & Co (LLY)JOHNSON & JOHNSON (JNJ)
Closing Price$1424.00$274.06
Market Cap$1.27T$659.7B
P/E (Latest FY)61.5x24.6x
P/B47.80x8.09x
Dividend Yield0.44%1.88%
Dividend Streak10 yrs10 yrs

FY2025 Side-by-Side Comparison

Latest fiscal year available for both companies (reported in USD).

Financial MetricELI LILLY & Co (LLY)JOHNSON & JOHNSON (JNJ)
Revenue ($B)65.1894.19
Net Income ($B)20.6426.8
Operating Cash Flow ($B)16.8124.53
Gross Margin83.0%67.9%
Net Margin31.7%28.5%
ROE101.2%35.0%
Debt-to-Assets76.4%59.1%
Dividends / Share ($)$6.23$5.14

Key Multi-Year Takeaways

  • Market capitalization: ELI LILLY & Co (LLY) trades at $1.27T, roughly 1.9x JOHNSON & JOHNSON's $659.7B.
  • FY2025 revenue scale: LLY generated $65.18B vs. JNJ's $94.19B.
  • Profitability: LLY posted a 31.7% net margin vs. 28.5% at JNJ in FY2025.
  • LLY 9-year revenue CAGR (2016–2025): +15.1%/yr.
  • JNJ 8-year revenue CAGR (2017–2025): +3.4%/yr.

Want AI competitive moat, catalyst, and scenario valuation research? Sign up free and verify your email for 2 free credits on LLY or JNJ.

10-Year Historical Trends

Aligned by fiscal year end across up to 10 annual SEC filings. Missing cells appear as “—”.

Revenue$B

LLYJNJ

025.050.075.0100FY2016 LLY: 18.3$BFY2017 LLY: 20.0$BFY2018 LLY: 21.5$BFY2019 LLY: 22.3$BFY2020 LLY: 24.5$BFY2021 LLY: 28.3$BFY2022 LLY: 28.5$BFY2023 LLY: 34.1$BFY2024 LLY: 45.0$BFY2025 LLY: 65.2$BFY2017 JNJ: 76.5$BFY2018 JNJ: 81.6$BFY2019 JNJ: 82.1$BFY2021 JNJ: 82.6$BFY2022 JNJ: 78.7$BFY2023 JNJ: 85.2$BFY2024 JNJ: 88.8$BFY2025 JNJ: 94.2$B16171819202122232425
Net Income$B

LLYJNJ

-10.0010.020.030.040.0FY2016 LLY: 2.7$BFY2017 LLY: -0.2$BFY2018 LLY: 3.2$BFY2019 LLY: 8.3$BFY2020 LLY: 6.2$BFY2021 LLY: 5.6$BFY2022 LLY: 6.2$BFY2023 LLY: 5.2$BFY2024 LLY: 10.6$BFY2025 LLY: 20.6$BFY2017 JNJ: 1.3$BFY2018 JNJ: 15.3$BFY2019 JNJ: 15.1$BFY2021 JNJ: 14.7$BFY2022 JNJ: 20.9$BFY2023 JNJ: 35.2$BFY2024 JNJ: 14.1$BFY2025 JNJ: 26.8$B16171819202122232425
Operating Cash Flow$B

LLYJNJ

010.020.030.0FY2016 LLY: 4.9$BFY2017 LLY: 5.6$BFY2018 LLY: 5.5$BFY2019 LLY: 4.8$BFY2020 LLY: 6.5$BFY2021 LLY: 7.4$BFY2022 LLY: 7.6$BFY2023 LLY: 4.2$BFY2024 LLY: 8.8$BFY2025 LLY: 16.8$BFY2017 JNJ: 21.1$BFY2018 JNJ: 22.2$BFY2019 JNJ: 23.4$BFY2021 JNJ: 23.5$BFY2022 JNJ: 23.4$BFY2023 JNJ: 22.8$BFY2024 JNJ: 24.3$BFY2025 JNJ: 24.5$B16171819202122232425
Return on Equity (ROE)%

LLYJNJ

-50050100150200FY2016 LLY: 20%FY2017 LLY: -2%FY2018 LLY: 30%FY2019 LLY: 134%FY2020 LLY: 150%FY2021 LLY: 76%FY2022 LLY: 64%FY2023 LLY: 49%FY2024 LLY: 85%FY2025 LLY: 101%FY2023 JNJ: 48%FY2024 JNJ: 20%FY2025 JNJ: 35%16171819202122232425
Expand year-by-year numbers (2016–2025)
FYLLY
Revenue ($B)
LLY
Net Income ($B)
LLY
Operating Cash Flow ($B)
LLY
Gross Margin (%)
LLY
Net Margin (%)
LLY
ROE (%)
JNJ
Revenue ($B)
JNJ
Net Income ($B)
JNJ
Operating Cash Flow ($B)
JNJ
Gross Margin (%)
JNJ
Net Margin (%)
JNJ
ROE (%)
201618.312.744.8577.3%14.9%19.5%——————
201719.97-0.25.6277.7%-1.0%-1.6%76.451.321.0666.7%1.7%—
201821.493.235.5278.2%15.0%30.2%81.5815.322.266.8%18.8%—
201922.328.324.8478.8%37.3%133.8%82.0615.1223.4266.4%18.4%—
202024.546.196.577.7%25.2%150.2%——————
202128.325.587.3774.2%19.7%76.4%82.5814.7123.5465.6%17.8%—
202228.546.247.5976.8%21.9%63.6%78.7420.8823.4170.3%26.5%—
202334.125.244.2479.2%15.4%48.9%85.1635.1522.7968.8%41.3%48.3%
202445.0410.598.8281.3%23.5%84.6%88.8214.0724.2769.1%15.8%20.1%
202565.1820.6416.8183.0%31.7%101.2%94.1926.824.5367.9%28.5%35.0%

Filing Sources & Links

Frequently Asked Questions

Popular U.S. Peer Matchups

NVIDIA vs. AMDApple vs. MicrosoftAlphabet vs. Meta PlatformsAmazon vs. WalmartCoca-Cola vs. PepsiCoVisa vs. MastercardJPMorgan Chase vs. Bank of AmericaChevron vs. ConocoPhillipsCostco vs. TargetHome Depot vs. Lowe'sBroadcom vs. QualcommSalesforce vs. OracleNetflix vs. Walt DisneyBlackstone vs. BlackRockGoldman Sachs vs. Morgan StanleyMerck vs. PfizerMcDonald's vs. StarbucksUPS vs. FedExCaterpillar vs. Deere

Explore more U.S. data: U.S. quality screeners (ROIC / F-Score / FCF Yield) · Intrinsic value calculator · 中文版:A 股财务对比工具 →

Compiled mechanically from public SEC XBRL filings and closing quotes. Not investment advice.